PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-37.40%
Negative revenue growth while ECL.AX stands at 24919.52%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
129.53%
Gross profit growth similar to ECL.AX's 138.07%. Walter Schloss would assume both firms track common industry trends.
556.16%
EBIT growth below 50% of ECL.AX's 1832.67%. Michael Burry would suspect deeper competitive or cost structure issues.
556.16%
Operating income growth under 50% of ECL.AX's 1832.67%. Michael Burry would be concerned about deeper cost or sales issues.
-88.90%
Negative net income growth while ECL.AX stands at 1996.86%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-100.00%
Negative EPS growth while ECL.AX is at 2016.33%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-100.00%
Negative diluted EPS growth while ECL.AX is at 2016.33%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
306.15%
Slight or no buybacks while ECL.AX is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
9.27%
Slight or no buyback while ECL.AX is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
126.09%
OCF growth above 1.5x ECL.AX's 53.53%. David Dodd would confirm a clear edge in underlying cash generation.
111.67%
FCF growth above 1.5x ECL.AX's 45.92%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-64.35%
Negative 10Y revenue/share CAGR while ECL.AX stands at 14.89%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-38.26%
Negative 5Y CAGR while ECL.AX stands at 147.96%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-75.66%
Negative 3Y CAGR while ECL.AX stands at 73.71%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
6692.19%
Positive long-term OCF/share growth while ECL.AX is negative. John Neff would see a structural advantage in sustained cash generation.
-75.19%
Negative 5Y OCF/share CAGR while ECL.AX is at 174.10%. Joel Greenblatt would question the firm’s operational model or cost structure.
-88.30%
Negative 3Y OCF/share CAGR while ECL.AX stands at 36.93%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
582.30%
Net income/share CAGR above 1.5x ECL.AX's 102.89% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-95.35%
Negative 5Y net income/share CAGR while ECL.AX is 234.27%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-97.71%
Negative 3Y CAGR while ECL.AX is 213.42%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-53.25%
Negative 5Y equity/share growth while ECL.AX is at 50.80%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-66.93%
Negative 3Y equity/share growth while ECL.AX is at 38.90%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-72.70%
Firm’s AR is declining while ECL.AX shows 18.49%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
136.98%
We show growth while ECL.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
37.29%
Asset growth above 1.5x ECL.AX's 10.02%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-75.05%
We have a declining book value while ECL.AX shows 7.21%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
69.85%
We have some new debt while ECL.AX reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
93.56%
SG&A declining or stable vs. ECL.AX's 1734.13%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.